Bruker BRKR
NASDAQ BRKR
$60.53 +1.88 (+3.21%)
At close: Aug 20, 2026 · 1:10 PM UTC

Bruker (BRKR) Restructuring Costs (2010 - 2025)

Bruker's (BRKR) quarterly Restructuring Costs came in at -$3.6 million in Q4 2025, down 117.73% YoY from $20.3 million in Q4 2024, and down 187.8% on a QoQ basis from $4.1 million in Q3 2025.

Bruker (BRKR) Restructuring Costs (2010 - 2025) Analysis & Trends

Bruker (BRKR) has 13 years of Restructuring Costs data on file, last reported at -$3.6 million in Q4 2025.

  • Quarterly Restructuring Costs fell 117.73% year-over-year to -$3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.9 million (up 3.46% YoY) and the FY2025 annual result came in at $6.4 million, down 79.22% from the prior year.
  • Restructuring Costs slipped to -$3.6 million in Q4 2025, from $4.1 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $20.3 million in Q4 2024 to a low of -$3.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn
10 Bruker 9.23 Bn 9.23 Bn 416.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.60 Mn
Sep 30, 2025 4.10 Mn
Dec 31, 2024 20.30 Mn
Sep 30, 2024 6.10 Mn
Sep 30, 2020 900,000.00
Dec 31, 2019 -1.30 Mn
Sep 30, 2019 900,000.00
Jun 30, 2019 1.20 Mn
Mar 31, 2019 3.80 Mn
Dec 31, 2018 1.10 Mn
Sep 30, 2018 1.20 Mn
Jun 30, 2018 100,000.00
Mar 31, 2018 1.00 Mn
Dec 31, 2017 700,000.00
Sep 30, 2017 500,000.00
Jun 30, 2017 2.90 Mn
Mar 31, 2017 400,000.00
Dec 31, 2016 900,000.00
Sep 30, 2016 200,000.00
Jun 30, 2016 7.90 Mn